Antibodies & Hybridomas — page 8 of 119
Antibodies & Hybridomas
Page 8 of 119
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 (COVID-19) Nucleocapsid | HL455 | Rabbit | sars coronavirus, sars coronavirus 2 | Protein A purified | 100 µl | n/a |
 GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | HL5410 | Rabbit | sars coronavirus, sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | HL5511 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | HL455-MS | Mouse | sars coronavirus, sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | polyclonal | Rabbit | sars coronavirus, sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Nucleocapsid | polyclonal | Rabbit | sars coronavirus, sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV / SARS-CoV-2 (COVID-19) Nucleocapsid | 6H3 | Mouse | sars coronavirus, sars coronavirus 2 | Protein G purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 0002 | Rabbit | SARS-CoV, SARS-CoV-2; | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 040 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 040 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 0006-1 | Rabbit | SARS-CoV, SARS-CoV-2; | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | monoclonal | Mouse | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | monoclonal | Mouse | SARS-CoV, SARS-CoV-2 | unconjugated | 20 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | monoclonal | Rabbit | SARS-CoV, SARS-CoV-2; | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | monoclonal | Rabbit | SARS-CoV, SARS-CoV-2; | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Delta B.1.617.2 | monoclonal | Recombinant Human | n/a | Protein A purified | 50 µg, 100 µg, | n/a |
 ABBEXA LTD |
More Info |
| SARS-CoV-2 RBD (Casirivimab biosimilar) | Casirivimab (REGN10933) | Recombinant | n/a | purified | 1mg, 5mg | n/a |
 KMD BIOSCIENCE CO. LTD. |
More Info |
| SARS-CoV-2 RBD (imdevimab biosimilar) | imdevimab (REGN10987) | Recombinant | n/a | purified | 1mg, 5mg | n/a |
KMD BIOSCIENCE CO. LTD. |
More Info |
| SARS-CoV-2 Spike Glycoprotein Neutralizing | 001 | Rabbit | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 (BA.2.75), SARS-CoV-2 (BA.2.3.20); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike Glycoprotein Neutralizing | 57 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.2 mg | n/a |
 BIORBYT LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |